RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model.
about
RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
RGN-259 (thymosin β4) improves ...... tion drugs in a dry eye model.
@en
RGN-259
@nl
type
label
RGN-259 (thymosin β4) improves ...... tion drugs in a dry eye model.
@en
RGN-259
@nl
prefLabel
RGN-259 (thymosin β4) improves ...... tion drugs in a dry eye model.
@en
RGN-259
@nl
P2093
P2860
P1433
P1476
RGN-259 (thymosin β4) improves ...... tion drugs in a dry eye model.
@en
P2093
Chae Eun Kim
Gabriel Sosne
George W Ousler
Hynda K Kleinman
Jaewook Yang
Kyeongsoon Kim
Sinwook Kang
P2860
P356
10.1038/S41598-018-28861-5
P407
P577
2018-07-12T00:00:00Z